Literature DB >> 17425749

Disability following kidney transplantation: the link to medication coverage.

D P Slakey1, M Rosner.   

Abstract

There is no uniformity regarding patient disability following kidney transplantation. Given improved results of patient and graft survival, and the link between insurance, medication coverage and disability, efforts must be made to define disability after a successful transplant. We conducted an individual questioner study of kidney transplant patients to determine factors relating to patient-perceived disability. Seventy patients participated in the study. Patient perception of disability did not correlate with education or ethnicity. Most patients believed they were disabled on dialysis and this did not change following transplantation. While 42 (60%) of the patients felt that they could work, either full-time or part-time, only 20 (28%) were actually working or in school. Most patients believe that working will eliminate disability status and, therefore, insurance and medication coverage. Patients considered disability more related to their status as a kidney transplant patient than any specific physical limitations. The link, whether real or perceived, between 'disability' and immunosuppressive medication coverage is a significant barrier for many patients. The transplant community must reach some degree of consensus regarding post-transplant activity restrictions. The transplant community needs to find a way to take an active role in post-transplant education and employment.

Entities:  

Mesh:

Year:  2007        PMID: 17425749     DOI: 10.1111/j.1399-0012.2006.00629.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  8 in total

1.  Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era.

Authors:  Matthew Kadatz; John S Gill; Jagbir Gill; Richard N Formica; Scott Klarenbach
Journal:  J Am Soc Nephrol       Date:  2019-11-08       Impact factor: 10.121

2.  Labor supply responses to government subsidized health insurance: evidence from kidney transplant patients.

Authors:  Timothy F Page
Journal:  Int J Health Care Finance Econ       Date:  2011-05-13

3.  Kidney transplant outcomes in recipients with visual, hearing, physical and walking impairments: a prospective cohort study.

Authors:  Alvin G Thomas; Jessica M Ruck; Nadia M Chu; Dayawa Agoons; Ashton A Shaffer; Christine E Haugen; Bonnielin Swenor; Silas P Norman; Jacqueline Garonzik-Wang; Dorry L Segev; Mara McAdams-DeMarco
Journal:  Nephrol Dial Transplant       Date:  2020-07-01       Impact factor: 5.992

4.  Factors related to participation in paid work after organ transplantation: perceptions of kidney transplant recipients.

Authors:  Nazanin Nour; Carol S Heck; Heather Ross
Journal:  J Occup Rehabil       Date:  2015-03

5.  Long-term health and work outcomes of renal transplantation and patterns of work status during the end-stage renal disease trajectory.

Authors:  Sijrike F van der Mei; Daphne Kuiper; Johan W Groothoff; Wim J A van den Heuvel; Willem J van Son; Sandra Brouwer
Journal:  J Occup Rehabil       Date:  2011-09

6.  Employment 12 months after kidney transplantation: An in-depth bio-psycho-social analysis of the Swiss Transplant Cohort.

Authors:  Brigitta Danuser; Amira Simcox; Regina Studer; Michael Koller; Pascal Wild
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

7.  Employment of patients with kidney failure treated with dialysis or kidney transplantation-a systematic review and meta-analysis.

Authors:  Lilli Kirkeskov; Rasmus K Carlsen; Thomas Lund; Niels Henrik Buus
Journal:  BMC Nephrol       Date:  2021-10-22       Impact factor: 2.388

8.  Predictors of return to work after kidney transplantation: a 12-month cohort of the Japan Academic Consortium of Kidney Transplantation study.

Authors:  Katsunori Miyake; Motoki Endo; Masayoshi Okumi; Kohei Unagami; Yoichi Kakuta; Miyuki Furusawa; Tomokazu Shimizu; Kazuya Omoto; Hiroki Shirakawa; Hideki Ishida; Kazunari Tanabe
Journal:  BMJ Open       Date:  2019-10-03       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.